newsfilter
← Latest News
Business Wire·

Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026

The Oncodetect® test expands the role of tumor-informed MRD in triple-negative breast cancer The Cancerguard® test demonstrates improved early-stage multi-cancer detection performance Exact Sciences Corp.